ABSTRACT. The influence of recombinant interferon-y (IFN-y) and tumor necrosis factor-cu (TNF) on IL-4-induced proliferation of postnatal human thymocytes from eight children with Down syndrome (DS, trisomy 21) and 18 control children was evaluated. DS thymuses were studied because they are characterized by cortical depletion and abnormal thymocyte differentiation. IL-4, without mitogen, induced a dose-dependent proliferation of both DS and control thymocytes. The proliferation was comparable to that induced by IL-2 and far greater than the proliferation mediated by IL-1@ in the absence of mitogen. The level of IL-4 responsiveness correlated with the proportion of cells expressing the y,6 chains of the T cell receptor. Furthermore, thymocyte preparations greatly enriched for T cell receptory,d-bearing cells were found to vigorously proliferate when treated with IL-4. Both IFN-y and TNF inhibited IL-4-driven proliferation in a dose-dependent manner, but DS thymocytes were found to be significantly more sensitive to inhibition by both cytokines. Our studies suggest an important role for IL-4 in the proliferation of T cell receptory,6+ thymocytes and demonstrate regulatory functions for IFN-y and TNF in human thymocyte proliferation. The increased sensitivity of DS thymocytes to IFN-y and TNF may explain anatomical abnormalities in DS thymuses and suggests the involvement of genes encoded on human chromosome 21 in the responses to both IFN-y and TNF. (Pediatr Res 32: 269-276,1992) Abbreviations DS, Down syndrome GAM, goat anti-mouse IFN-y, interferon-? TCR, T cell receptor TNF, tumor necrosis factor-a r, recombinant
Individuals with DS (trisomy 21) have multiple immunologic and hematologic abnormalities (1-3). Their thymuses show altered patterns of thymocyte differentiation (4, 5) and have numerous anatomical abnormalities, including depletion of cortical thymocytes, loss of cortico-medullary demarcation and enlarged Hassall's corpuscles (1, 6, 7). Also, we recently found evidence for an inefficient release by the DS thymus of mature T cells into the periphery (8) . It is unclear which chromosome 21-encoded gene or genes if overexpressed in trisomic cells may be responsible for the abnormalities of thymic anatomy and thymocyte maturation observed in DS. However, it is known that human chromosome 21 does encode some aspect of the response to IFN--y (9, lo), making trisomy 21 cells more sensitive to the effects of this cytokine (I 1,12) . Taken together, these facts make the study of the effects of IFN-7, and its interaction with other cytokines, on DS thymocyte proliferation and maturation particularly appropriate.
The importance of the thymus for the continuous production, maturation, and selection of T cells is well established. There is increasing evidence that cytokines play a role in the regulation of thymocyte maturation (1 3). IL-4, originally described as a B cell stimulatory factor (14) , has been shown to promote in vitro proliferation of murine (1 5-21) and human (22) (23) (24) (25) thymocytes. However, the cell type(s) that proliferates in response to IL-4 has not been clearly established. There is also evidence that IL-4 is a differentiation factor for immature T cell precursors in fetal murine (15) or postnatal human thymus (25, 26) . Support for an important role of IL-4 in thymocyte proliferation and differentiation is strengthened by the observations that immature murine thymocytes express high affinity receptors for IL-4 (27) and can be stimulated to produce IL-4 in vitro (16, 28, 29) . In addition, constitutive expression of IL-4 mRNA has been identified by in situ hybridization in fetal murine thymocytes (30) and in CD3-CD4-CD8-T cell precursors isolated from postnatal human thymus (26) .
To elucidate the importance of IL-4 in human thymocyte proliferation, we have examined the effects of purified rIL4 on postnatal human thymocytes from eight DS and 18 control children. We have found that IL-4 induces a dose-dependent proliferation of both DS and control thymocytes in vitro and does not require the addition of exogenous mitogen. Using a new method for purification of human TCRy,G-bearing thymocytes, we have also demonstrated that TCRr,6+ human thymo- cytes are an important target of the proliferation-inducing effects of IL-4.
IFN-y (29, 31) and TNF (32, 33) are also produced by immature thymocytes and have been shown to influence thymocyte proliferation in vitro (29, (32) (33) (34) (35) (36) . In particular, IFN-y has been shown to inhibit IL-4-induced proliferation of phorbol esterstimulated murine thymocytes (29) . We have examined the influence of rIFN-y and rTNF on IL-4-induced proliferation of DS and control thymocytes and demonstrated that both cytokines mediate a dose-dependent inhibition of IL-4-mediated proliferation. In addition, we observed that DS thymocytes are far more sensitive to the inhibitory effects of both IFN-y and TNF.
Our observations define a possible role for IL-4 in the proliferation of TCRy,G-bearing thymocytes. They also demonstrate that IFN-y and TNF have important regulatory roles in human thymocyte proliferation. Furthermore, the fact that DS thymocytes have an increased sensitivity to both IFN-y and TNF suggests a mechanism for the lymphocyte depletion and abnormal thymocyte differentiation observed in DS thymuses. It also implicates the possible involvement of genes encoded on human chromosome 21 in the response not only to IFN-y but also to TNF.
MATERIALS AND METHODS
Cytokines. Purified human rIL-4 (sp act 2 x lo6 U/mg) was obtained from Dr. Alan Levine of Monsanto Co. (St. Louis, MO). A unit of IL-4 is defined as the amount of IL-4 required to cause half-maximal stimulation of 3H-thymidine incorporation by phytohemagglutinin-stimulated human peripheral blood lymphocytes (22) . Purified human rIFN-y (sp act 2.5 x lo7 U/ mg) and rTNF (sp act 5.7 x lo7 U/mg) were gifts from Dr. H. M. Shepard (Genentech, Inc., So. San Francisco, CA). Purified human rIL-2 (sp act 6.2 x lo6 U/mg) was purchased from Collaborative Research, Inc. (Bedford, MA). Purified human rIL-1P (sp act 1 x 10' U/mg) was purchased from Genzyme Cytokine Research Products (Boston, MA).
Antibodies. MAb anti-Leu-4, anti-Leu-3a/b, anti-Leu-2a, and anti-TCR-I, reacting with CD3, CD4, CD8, and TCRa,P (37), respectively, were obtained from Becton Dickinson Immunocytochemistry Systems (San Jose, CA) and were used as FITC conjugates. Anti-TCR-81 (IgGl), reacting with the 6 chain of the human TCR (38) , was a gift of Dr. M. Brenner (Dana-Farber Cancer Institute, Boston, MA). Optimal concentrations of anti-TCRG1 ascites fluid was used for purification of TCRy,G' thymocytes and, in most experiments, for the phenotypic analysis of thymocytes by indirect immunofluorescence. FITC-conjugated anti-TCRF 1, purchased from T Cell Sciences (Cambridge, MA), was used in indicated experiments. Neutralizing antibodies to human IL-2 and IFN-a were purchased from Collaborative Research, Inc. Neutralizing antibody to human IFN-P was a gift from Dr. Alfons Billiau, University of Leuven (Leuven, Belgium). Neutralizing antibody to human IFN-y was generously provided by Drs. B. Perussia and G. Trinchieri of The Wistar Institute (Philadelphia, PA) and neutralizing antibody to human TNF was a gift from Dr. H. M. Shepard, Genentech, Inc.
cDNA probes. A 710-bp fragment of the pLW55 plasmid containing the human IL-2 cDNA (purchased from the American Type Culture Collection, Rockville, MD) was used to detect human IL-2 mRNA. A 900-bp fragment of the human IFN-y cDNA plasmid p52 (provided by Dr. D. Goeddel, Genentech, Inc.) was used to detect human IFN-y mRNA.
Human thymocyte preparations. Sterile samples of human thymus, routinely removed during corrective cardiac surgery, were obtained with the help of Dr. Kevin Turley and the members of the Department of Surgery, University of California, San Francisco. All thymus samples included in the study were from children less than 2 y of age. All DS children were diagnosed as trisomy 21 by phenotypic and cytogenetic analysis. Children with recent infections and children treated with medications known to affect immunologic development or function were excluded from the study. Thymic tissue was dissociated in PBS, and a single cell suspension was obtained by sequential passage through 18-, 20-, and 23-gauge needles. Viable mononuclear cells were isolated by gradient centrifugation with Ficoll-Hypaque (1.077 g/mL; Pharmacia, Piscataway, NJ) (39) , washed three times with PBS, and depleted of stromal cells by adherence to plastic (3772, 1 h). The resulting cell populations always contained > 98% thymocytes as identified by reactivity with anti-CD2 MAb (anti-Leu-5b, Becton Dickinson).
Purification of TCRy,G-bearing thymocytes. Nonadherent thymocytes (10 x lo7 cells/mL) were reacted for 45 min at 4°C with optimal concentrations of anti-TCRG 1 (IgG 1, 38) ascites fluid that had been extensively dialyzed against PBS and sterile filtered. Antibody-sensitized cells were washed twice with cold PBS containing 1% BSA and then reacted for 30 min at 4°C with an optimal concentration of biotinylated rat anti-mouse IgGl MAb (CellPro, Inc., Bothell, WA). Cells were washed as above, and the biotin-bound cells were positively selected by loading the cell suspension (10 x lo7 cells/mL in PBS-1% BSA, 3-6 mL per column) onto an avidin-gel column using the Ceprate LC Laboratory Cell Separation System provided by CellPro, Inc. Loading and elution of bound and unbound cells were performed according to the manufacturer's instructions and required less than 1 h to perform. The purification of bound and unbound cells was monitored immediately after purification by reactivity with optimal concentrations of afinity-purified FITC-conjugated goat F(abf)2 anti-mouse IgG (GAM-FITC, Organon Teknika, West Chester, PA). The bound cells were also cultured for 18 h at 37°C in RPMI-1640-10% FCS, washed extensively, and analyzed for anti-TCRGI reactivity to confirm purification. The purity of TCRy,G-bearing thymocytes was comparable by both methods used to assess purity. This purification method yielded an average of 2 x lo6 viable cells with an average purity of at least 86% anti-TCRG 1+ cells.
Measurement of thymocyte proliferation by 3H-thymidine incorporation. Replicate wells of unseparated, CD4-CD8--enriched, or anti-TCRGl+ or TcRGl-thymocytes were cultured at 37°C in sterile, flat-bottom, 96-well tissue culture plates (1 x lo5 cells/200 pL) in RPMI-1640-10% FCS containing the indicated concentrations of rIL-4, rIL-2, rIGlP, rIFN-y, or rTNF. Cytokines were always added at the initiation of culture. Wells were pulsed with 1 pCi/well 3H-thymidine (Amersham Corp., Arlington Hills, IL; sp act 2 Ci/mmol) on d 5 of culture and harvested onto glass-microfiber filters after 18 h using a semiautomated cell harvester (Skatron, Inc., Sterling, VA). The amount of 3H-thymidine incorporated was assessed by liquid scintillation counting of filters.
Analysis of surface antigen expression by imrnunofluorescence andflow cytometry. After isolation or culture, cells were washed three times with PBS and reacted with MAb for 30 min at 4°C
(1 x lo6 cells/100 pL). Optimal concentrations of MAb were used according to the manufacturer's instructions or results of titration. After exposure to fluorochrome-conjugated specific MAb, cells were washed three times with cold PBS containing 0.1 % gelatin (Sigma Chemical Co., St. Louis, MO) and 0.1 % NaN3 (Sigma) and fixed with 2% paraformaldehyde (Sigma) in PBS for 10 min at 25°C. For staining with unconjugated anti-TCRG1, cells were washed three times as above, reacted with optimal concentrations GAM-FITC for 30 min at 4"C, washed, and fixed as above. Cells stained with fluorochrome-conjugated nonspecific mouse IgG (Becton Dickinson) or GAM-FITC alone were used as negative controls. Ten thousand to 20 000 viable cells were analyzed on a FACScan flow cytometer (Becton Dickinson). Size thresholds and gates were used to exclude dead cells and cellular debris from analysis.
Extraction of total cellular RNA and Northern analysis. After culture with the indicated cytokines, 10-20 X lo6 cells were washed three times with PBS and total RNA was prepared using RNAzol (CinnalBiotecx, Friendswood, TX) as previously described (40) . Two to 5 pg of total RNA was electrophoresed on 1 % agarose gels, and the gels were blotted and hybridized with "P-labeled cDNA inserts as previously described (40) .
Statistical tests. A two-tailed t test was used for the statistical analysis of data comparing the results from DS and controls.
RESULTS

ZL-4 effects on thymocyte proliferation.
To determine whether IL-4 could induce proliferation of human postnatal thymocytes without the addition of mitogen, nonadherent mononuclear thymocytes (>98% CD2+) were cultured in various concentrations of IL-4 for 5 d and proliferation was assessed by 3H-thymidine incorporation. Kinetic analysis showed d 5 to be the time of peak 3H-thymidine incorporation, followed at d 6 by the appearance of numerous large, blast-like cells and an increase in viable cell number. IG4 induced a dose-dependent proliferative response that was significant at concentrations as low as 1 ng/ mL and optimal for both DS and controls at 10 ng/mL (Fig. 1) .
The proliferative response to IL-4, in the absence of mitogen, was comparable to that induced by well-established thymocyte growth factors. Figure 1 shows the results of a representative experiment in which the dose-dependent proliferation of control thymocytes to IL-4, IL-2, and IL-10 was compared. IL-4, in the absence of mitogen, induced proliferation that was comparable to that induced by IL-2 without mitogen. IL-4 was generally more potent at lower protein concentrations (10 ng/mL) than was IL-2. In the absence of mitogen, IL-10, at the concentrations tested, did not induce proliferation of nonadherent mononuclear cells from human thymus. The proliferation-inducing effects of all three cytokines were enhanced in the presence of 25 pg/mL phytohemagglutinin (data not shown).
Proliferation of DS and control thymocytes in response to ZL-4. The proliferative response of 18 control and eight DS thymocyte preparations to an optimal concentration of 10 ng/mL of IL-4 is shown in Figure 2 . Both DS and control thymocytes proliferate in response to IL-4. The DS thymocytes, as a group, showed slightly lower levels of response to IL-4 than the controls (with median cprn X of 4.32 and 5.74, respectively), but this difference was not found to be statistically significant.
Correlation of ZL-4 response with proportion of TCRy,G+ cells. There was considerable variability in the proliferative response to IL-4 among both control and DS thymocyte preparations The ages of the subjects examined are shown in the left column.
tested (Fig. 2) . Figure 3 demonstrates the range of responses of the 18 control thymocyte preparations to 10 ng/mL of IL-4, with the shaded area representing the mean + SEM (14.63 f 3.97 cprn x for the entire group. The mean response for cells cultured in the absence of IL-4 was 0.63 f 0.09 cprn x Although younger subjects tended to show higher proliferative responses to IL-4, regression analysis did not reveal any statistically significant correlation between IL-4 responsiveness and age.
To determine the cell type@) that is responsive to IL-4-induced proliferation and to ascertain the reason for the variability in IL-4 responsiveness among thymocyte preparations, we examined the correlation of the proliferative response to IL-4 (10 ng/mL) to the proportions of various thymocyte subpopulations, as de-termined by dual-color 'immunofluorescence and flow cytometry. There was no significant correlation between IL-4 responsiveness and the proportion of TCRo(,P+ (dim or bright), CD3+ (dim or bright), CD4-CD8-, CD4+CD8+, CD4+CD8-, or CD4-CD8+ thymocytes. However, Figure 4 , which depicts the results of regression analysis correlating the proliferative response to IL-4 to the proportion of TCRy,G cells in total thymocyte populations from five control children, demonstrates that IG4-induced proliferation is proportional to TCRy,G cell content (R = 0.89).
Development of new method for isolation ofpurified TCRy,G+ thymocytes. To demonstrate directly that TCRy,G+ thymocytes proliferate in response to IL-4, we sought to purify TCRy,G cells from human thymus. We first attempted purification by fluorescence-activated cell sorting. However, fluorescence-activated cell sorting separation took as long as 30 h to separate the requisite number of cells from total thymocyte populations and resulted in poor viability. Therefore, we developed a new procedure for positive selection of TCRy,G cells. Using an avidin-gel column system provided by CellPro, Inc., we took advantage of the fact that the pan TCRy,G MAb, anti-TCRG1 (38) , is a mouse IgGl MAb and would react with the biotinylated rat anti-mouse IgGl MAb developed for use with the avidin-gel column system. Figure 5 shows histograms of the immunofluorescence analysis of a representative experiment in which TCRy,G thymocytes were purified from a control thymus using the avidin-gel column system. Only 1-5% of human postnatal thymocytes have been shown to express TCRy,G (Fig. 4) (41-43) . The top panel shows reactivity of the total thymocyte population with anti-TCRGl MAb. In this experiment, 4% of the total thymocytes reacted with anti-TCRG 1 before purification. Immediately after purification, the bound cells that were eluted from the column were phenotyped by reactivity with GAM-FTTC. In this experiment, 84% of the freshly purified cells reacted with GAM-FITC, indicating the presence of anti-TCRG 1 MAb on the cell surface (data not shown). The bound cells were also incubated in medium for 1 8 h at 37°C to regain reactivity with anti-TCRG 1, and the results are shown in the bottom panel. In this experiment, which is representative of five performed, 87% of the purified cells reacted with anti-TCRG1 after the 18-h culture and the level of fluorescence was well above that observed for purified cells reacted with nonspecific mouse IgG alone (depicted by the broken line). In all five experiments, the results obtained by phenotypic analysis with GAM-FITC immediately after purification and those ob- 
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Fig . 5 . Purification of TCRy,G+ thymocytes by avidin-gel columns. A representative experiment, of five performed, in which total nonadherent thymocytes were purified using the avidin-gel column system. Cells eluted from the column were incubated in medium for 18 h at 37"C, washed extensively, and analyzed for reactivity with FITC-conju- tained after 18 h incubation and reactivity with anti-TCRG1 were comparable. These estimates of purity may be conservative, considering the difficulty in performing immunofluorescence analysis on cells that have previously been reacted with antibody. The advantage of this procedure is that it requires only 2 h to perform and yields a highly purified population of TCRy,G cells with a viability of greater than 95%. Figure 6 shows the results from three separate control thymuses in which we examined the IL-4-induced proliferation of purified TCRy,G cells as compared to total (unseparated) thymocytes and thymocytes that did not bind to the columns and were partially depleted of TCRy,G cells. In all three experiments, purified TCRy,G cells showed a greatly enhanced proliferative response to IL-4 as compared with the response of unseparated thymocytes. Of import was our additional observation that the proliferation of purified TCRy,G cells cultured without IL-4, but in medium alone, was not significantly higher than that of total thymocytes cultured in medium alone, demonstrating that the process of purification itself did not induce proliferation. (29) . To determine if human thymocyte proliferation is also regulated by IFN-y, we tested the effects of varying concentrations of IFN-y on IL-4-induced proliferation. The effects of TNF were also evaluated. Figure 7 Exp. 1 Exp. 2 Exp. 3 depicts a representative experiment demonstrating the inhibition of IL-4-induced proliferation of unseparated control thymocytes by IFN-y (top panel) or TNF (bottom panel). Both cytokines elicited a dose-dependent inhibition of IL-4-induced thymocyte proliferation that was optimal at concentrations of 1-10 ng/mL. Synergistic inhibition of IL-4-induced proliferation by the combination of suboptimal concentrations of IFN-y and TNF was not observed. Proliferation of purified TCRy,G cells was also inhibited by 30% by IFN-y (6.7 ng/mL) and 21% by TNF (2.5 ng/mL) in one experiment, comparable to the inhibition observed for total, unseparated thymocytes (Fig. 8) . IFN-y or TNF alone, in the absence of IL-4, did not affect spontaneous thymocyte proliferation of total thymocytes or purified TCRy,G cells.
Proliferation of purified TCRy,G cells in response to IL-4.
IFN-y and TNF inhibition of IL-4-induced thymocyte proliferation. IFN-y has been shown to inhibit the IL-4-induced proliferation of murine thymocytes
Greater sensitivity of DS thyrnocytes to inhibitory effects of IFN-y and TNF. We have shown that DS fibroblasts are more sensitive to IFN-y (1 1, 12) . Therefore, we examined whether DS thymocytes are also more sensitive to inhibition of IL-4-induced proliferation by IFN-y. In addition, because of our finding that TNF inhibits IL-4-induced proliferation, we also examined the effects of TNF on IL-4-mediated proliferation by DS thymocytes. Proliferation was induced in DS thymocyte preparations and controls by the optimal concentration of 10 ng/mL IL-4. Optimal inhibitory concentrations of IFN-y (6.7 ng/mL) and TNF (2.5 ng/mL) were added at the initiation of culture. As expected, DS thymocytes were more sensitive to inhibition by IFN-y, with a mean of 45% inhibition compared to 27% for controls (p < 0.01) (Fig. 8, left panel) . To our surprise, we found that DS thymocytes were also more strongly inhibited by TNF, with a mean of 56% inhibition compared to 25% for controls (p < 0.02) (Fig. 8, right panel) . Although the mean response of the DS group to IL-4 alone was lower than that of the controls (Fig.  8, legend) , this is unlikely to explain the increased sensitivity to IFN-y or TNF, because there was no correlation between responsiveness to inhibition by IFN-y or TNF and the level of IL-4-induced proliferation of a given thymocyte preparation. DISCUSSION We have demonstrated that postnatal human thymocytes from both control and DS children proliferate in a dose-dependent manner to IL-4 and that this proliferation is unlike the IL-4-mediated proliferation of murine thymocytes, which requires a second signal such as that supplied by mitogen or phorbol ester (15) (16) (17) (18) (19) (20) (21) . This difference between the response of human and murine thymocytes may be explained by differences in either the number or affinity of IG4 receptors on thymocytes. Immature murine thymocytes have been shown to express few high-affinity IL-4 receptors, the number of which is greatly enhanced by activation with phorbol ester (27) . It is possible that postnatal human thymocytes constitutively express higher numbers of I G 4 receptors, alleviating the need for previous activation. In support of a species difference in IG4 responsiveness, the induction by IL-4 of IgE synthesis in human peripheral blood mononuclear cells is not dependent on the addition of mitogen (44), whereas IL-4-mediated induction of IgE in murine cells requires previous activation with mitogen (45).
In the absence of mitogen, IG4-stimulated human thymocyte proliferation occurs to an extent that is comparable to that induced by IL-2 and far greater than that induced by IL-ID. The IL-4-induced proliferation is independent of IL-2 because antibody to human IL-2, which effectively inhibited IL-2-induced proliferation, had no effect on the thymocyte proliferation stimulated by IL-4. Furthermore, IL-2 mRNA or protein was not detected in cultures of IL-Cstimulated cells (data not shown). IL-1 without the addition of mitogen did not induce significant proliferation of human postnatal thymocytes. Class I1 MHCf accessory cells have been shown to be necessary for IL-1 -induced thymocyte proliferation (33, probably due to the production of 47) . This suggests that our cultures, which were performed on nonadherent thymocyte preparations, may contain relatively few such accessory cells. However, it remains possible that low levels of thymic stromal cells were present in our cultures and that the activation of these cells, before or during culture, resulted in the production of numerous cytokines that may influence thymocyte proliferation (48, 49). Using the very sensitive technique of in situ hybridization, we have recently documented that both normal and DS thymuses contain cells that constitutively express IFN-y and TNF mRNA and that DS thymuses contain 2-fold and 3.9-fold elevated numbers of IFNy-and TNF mRNA-expressing cells, respectively, than agematched control thymuses (50). These results suggest that the thymocytes used in our experiments are likely to have been exposed to these cytokines before culture. In support for the endogenous production of TNF in our IL-4 cultures, we observed in two experiments that thymocytes cultured with IL-4 in the presence of neutralizing antibody to TNF proliferate to a greater extent than thymocytes cultured in IL-4 alone. Our finding of elevated levels of IFN-y and TNF in DS thymuses, as well as the increased sensitivity of DS thymocytes to these cytokines, suggests an explanation for the slightly lower proliferative response of DS thymocytes to IL-4. The considerable differences in the level of response to IL-4 among both the DS and the control thymocyte preparations examined is of interest. Although thymocytes from younger children were generally more responsive to IL-4, there was no obvious correlation between age and IG4 responsiveness for either group. However, we did observe good correlation between the proportion of TCRy,G-bearing cells in thymocyte populations and IL-4 responsiveness, suggesting that the variability in the proliferative response to IL-4 may be due to differences in the proportion of TCRy,G cells. It is possible that the slightly lower median response of DS thymocytes to IL-4 may also be due to a lower proportion of TCRy,G cells in DS thymuses. However, thus far, we have observed no statistically significant difference in the proportion of TCRy,G cells in DS ( n = 3) and control (n = 7) thymuses examined (1.7 and 1.4%, respectively).
Using a new and rapid avidin-gel column method for the purification of human TCRy,G-bearing thymocytes, we have demonstrated that positively selected TCRy,G cells proliferate in response to IL-4. Human TCRy,G cells are CD3+ and predominantly CD4-CD8-(41-43), although expression of CD4 (43, 5 1) and CD8 (41-43) on TCRy,G cells has been observed. Our demonstration that human TCRy,G-bearing thymocytes proliferate in response to IL-4 is consistent with reports in the murine system that IG4-responsive thymocytes are generally CD4-CD8-(1 5, 16, 19, 21, 27) . It is also consistent with reports suggesting that IL-4-responsive human thymocytes (24) or bone marrow cells (52) are CD3+. By directly purifying TCRy,G cells using positive selection, we have eliminated many of the problems presented by working with heterogenous populations of CD4-CD8-thymocytes. We cannot rule out the possibility that our purified TCRy,G cells have been stimulated by cross-linking of the TCR. However, our data correlating IL-4 responsiveness with the percentage of TCRy,G cells in unseparated thymocyte populations suggests that resting TCRy,F cells also proliferate in response to IL-4. Our studies define IL-4 as an important proliferation factor for TCRyG-bearing human thymocytes. Barcena et al. (25, 26) have shown that purified CD3-CD4-CD8-human thymocytes proliferate in response to IL-4 and that IL-4 can induce these cells to differentiate into TCRy,G cells in vitro.
Therefore, IL-4 has effects not only on TCRy,G cells but on their precursors as well and plays a role in the maturation of human TCRy,G cells.
It is clear from our results, and those of others, that IG4 has potent effects on developing thymocytes. In vivo data in IL-4 transgenic mice (53, 54) or murine fetal thymic organ culture (55, 56) suggest that overexpression of IL-4 results in a depletion of CD4+CD8+ thymocytes (53-56) and an inhibition in the production of TCRa,P-bearing cells (55, 56). Two explanations for the depletion of TCRa,P cells in these thymuses are possible. Given the known antagonism of the effects of-IG2 by IL-4 in other systems (57-59), the first possibility is that overexpression of IL-4 prevents the production or activity of IL-2, which has been proposed to play a critical role in differentiation of TCRa,P cells (19, 25, 26, (60) (61) (62) (63) . In light of our observation that IL-4 induces proliferation of TCRy,G-bearing thymocytes, the other possibility is that overexpression of IL-4 results in an increase in the proportion of TCRy,G cells and that TCRy,G cells (64), or cytokines produced by them (65), may influence TCRa,P cell maturation.
Although analysis of the effects of purified rIG4 on human thymocytes in vitro is critical in defining a role for IL-4 in thymocyte proliferation and differentiation, other signals, including numerous other cytokines, are present in the thymus in vivo and may influence the effects induced by IL-4. For example, I G 4-mediated effects on the growth of murine fetal thymic organ cultures (56) and on mitogen-stimulated murine thymocytes in vitro (29, 66) were reversed by the addition of IFN-7 to the cultures. We also found antagonistic effects between IFN-y and IG4 in our human system, in that IFN-y inhibited IL-4-induced proliferation of human thymocytes in a dose-dependent manner, with DS thymocytes being more strongly inhibited by IFN-y than the controls. The 1.7-fold increased inhibition by IFN-y of DS thymocytes compared to control thymocytes further illustrates the increased sensitivity of trisomy 21 cells to the effects of IFN-y (1 1, 12) and conforms to expected gene-dosage effects due to an extra copy of a chromosome 21-encoded gene(s).
We observed that TNF also inhibits IL-4-mediated proliferation of human thymocytes. This finding was unexpected considering that TNF has been shown to have comitogenic effects on murine (33) (34) (35) (36) or human (32) thymocyte proliferation when added together with IL-1 (34-36), IG2 (32-34), or IL-4 (34). It is possible that the differences between human and murine thymocytes are due to differences in the expression of TNF receptors. Two distinct receptors for human (67-70) and murine (71) TNF have recently been identified and cloned. The 75-kd form of the murine TNF receptor, termed TNF-R2, has been shown to be responsible for the initiation of signals for murine thymocyte proliferation and to be the species-specific form of the TNF receptor (72). It is not known whether the comparable form of the human TNF receptor mediates the same effects as has been observed in the murine system.
It is unclear why DS cells are 2.2-fold more sensitive to inhibition by TNF. It is possible that DS cells express relative differences in the abundance of one or both of the TNF receptors. However, neither receptor is encoded on human chromosome 21 (73) . We also explored the possibility that TNF-mediated inhibition could be due to induction of IFN-a, -P, or -7, inasmuch as DS cells are more sensitive to all three interferons (1 1), but we were unable to detect mRNA for IFN-y in thymocytes cultured with IL-4 and TNF for 2 or 5 d. Furthermore, neutralizing antibodies to human IFN-a, -P, or -y did not block TNFmediated inhibition of IL-4-driven proliferation. In a reciprocal fashion, an MAb to TNF did not block IFN-y-mediated inhibition, whereas it completely neutralized the inhibition caused by TNF (data not shown). Our current theory is that heightened sensitivity to TNF by DS thymocytes occurs because chromosome 21 encodes an additional gene or genes that confer sensitivity to TNF, or that the as yet undefined chromosome 21-encoded IFN--/ response element (74-76) may also play a role in the response to TNF.
An ordered and highly regulated production of cytokines in the thymus is most likely necessary for normal thymocyte maturation (13) . Careful analysis of the production of cytokines by purified, freshly isolated human TCRy,G cells obtained by our new procedure will aid in elucidating the role of TCRy,G cells and in understanding the signals required for normal thymocyte maturation. In addition, our findings of increased sensitivity of DS cells to the inhibitory effects of IFN-y and TNF suggest a mechanism in which a perturbation in the response to one or several cytokines may result in abnormal patterns of thymocyte maturation.
